Insulin-Dextrose Infusion for Diabetic Patients NBM Overnight
For diabetic patients who are nil-by-mouth (NBM) overnight, use a basal-plus insulin approach consisting of basal insulin (0.1–0.25 U/kg per day) with correction doses of rapid-acting insulin every 4-6 hours, rather than an insulin-dextrose infusion protocol. 1
Recommended Approach
For Patients with Type 1 or Type 2 Diabetes on Insulin
The basal-plus regimen is specifically designed for fasting patients and those undergoing procedures 1. This approach involves:
- Basal insulin: Single daily dose at 0.1–0.25 U/kg per day
- Correction insulin: Rapid-acting insulin administered every 4-6 hours based on point-of-care blood glucose readings 2
- Target glucose range: Maintain blood glucose below 10.0 mmol/L (180 mg/dL) 1
This strategy avoids the complexity and nursing intensity of continuous insulin-dextrose infusions while maintaining adequate glycemic control.
For Patients with Type 2 Diabetes Not on Insulin
If the patient has well-controlled type 2 diabetes managed with oral agents at home, use correction insulin (sliding scale) alone initially 1. Add basal insulin only if glucose levels cannot be maintained below 10.0 mmol/L (180 mg/dL) 1.
Why Not Routine Insulin-Dextrose Infusions?
Insulin-dextrose infusions are not the standard approach for routine NBM management in non-critical care settings. The evidence shows:
- Dextrose infusions are indicated primarily for treating hypoglycemia (insulin shock), not for routine glycemic management 3
- Continuous insulin infusions require hourly glucose monitoring and frequent rate adjustments, creating significant nursing burden 4
- The basal-plus approach achieves similar glycemic control with far less complexity 1
When Dextrose Should Be Added
Dextrose infusion becomes necessary in specific circumstances:
- During DKA management: Start dextrose when blood glucose falls to approximately 11.1 mmol/L (200 mg/dL) while continuing insulin infusion 5
- If hypoglycemia develops: Administer 10-25 grams of dextrose (20-50 mL of 50% dextrose) for blood glucose <3.9 mmol/L (70 mg/dL) 3
- For prolonged fasting with insulin: Consider dextrose 5-10% infusion if patient remains NBM for extended periods while receiving basal insulin to prevent hypoglycemia
Critical Pitfalls to Avoid
Hypoglycemia Risk
The basal-bolus approach carries 4-6 times higher hypoglycemia risk than correction insulin alone 1. Reduce insulin doses in high-risk patients:
- Age ≥65 years
- BMI ≤27 kg/m²
- Chronic kidney disease (eGFR <60 mL/min)
- Total daily insulin dose ≥0.6 U/kg
- History of hypoglycemia 2
For these patients, use lower basal insulin doses (0.1 U/kg) and monitor glucose every 4 hours 1.
Avoid Sliding Scale Insulin Alone in Type 1 Diabetes
Never use correction insulin (sliding scale) as monotherapy in type 1 diabetes patients 1. These patients have absolute insulin deficiency and require basal insulin coverage even when fasting to prevent diabetic ketoacidosis.
Premixed Insulin
Do not use premixed insulin (70/30) in hospitalized patients due to unacceptably high hypoglycemia rates 1.
Monitoring Protocol
- Check blood glucose every 4-6 hours for patients on basal-plus regimen 2
- Administer correction insulin based on pre-established correction scales
- For high-risk patients, consider real-time continuous glucose monitoring with confirmatory point-of-care testing for insulin adjustments 2
Dose Adjustments
If the patient was on insulin at home:
- Low home doses (<0.6 U/kg/day): Start with 0.1-0.25 U/kg basal insulin
- High home doses (≥0.6 U/kg/day): Reduce total daily dose by 20% to prevent hypoglycemia during reduced oral intake 1
The key principle is that routine insulin-dextrose infusions are reserved for critical care settings or specific situations like DKA management, not for standard NBM glycemic control in ward patients.